Unlock instant, AI-driven research and patent intelligence for your innovation.

Chinese medicinal compound preparation for treating uterine myoma

A compound preparation and technology for uterine fibroids, applied in antineoplastic drugs, pharmaceutical formulas, medical preparations containing active ingredients, etc., can solve problems such as side effects, and achieve a short course of treatment with definite and obvious effects

Inactive Publication Date: 2011-11-30
ZHONGSHAN HYGENE BIOPHARM
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. Among the hormones, Kessin Pills smg, take orally or intramuscularly inject 251ng of Kessine Propionate Pills, the total amount of each month should not exceed 300mg, clinical observation, choose this medicine, and it has side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese medicinal compound preparation for treating uterine myoma
  • Chinese medicinal compound preparation for treating uterine myoma
  • Chinese medicinal compound preparation for treating uterine myoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Embodiment 1 of the oral preparation of the present invention consists of the following components in parts by weight:

[0053]

[0054] After the above-mentioned medicines are prepared, they are crushed through a 200-mesh sieve, and the fine powder is packed into capsules to obtain the oral capsule preparation of the present invention. Dosage: 6-10 grams per serving, 2-3 times a day.

[0055] Embodiment 1 of the preparation for external application of the present invention consists of the following components in parts by weight:

[0056]

[0057] After the above-mentioned medicines are proportioned according to the dosage, they are crushed into a coarse powder, and the coarse powder is packed into a 100-gram pouch, steamed in an oven, and then applied to the abdomen externally, once every day.

Embodiment 2

[0058] Embodiment 2 of the oral preparation of the present invention consists of the following components in parts by weight:

[0059]

[0060] After the above-mentioned medicines are prepared, they are crushed through a 200-mesh sieve, and the fine powder is packed into capsules to obtain the oral capsule preparation of the present invention. Dosage: 6-10 grams per serving, 2-3 times a day.

[0061] Embodiment 2 of the external application preparation of the present invention consists of the following components in parts by weight:

[0062]

[0063] After the above-mentioned medicines are proportioned according to the dosage, they are crushed into a coarse powder, and the coarse powder is packed into a 100-gram pouch, steamed in an oven, and then applied to the abdomen externally, once every day.

Embodiment 3

[0064] Embodiment 3 of the oral preparation of the present invention consists of the following components in parts by weight:

[0065]

[0066]

[0067] After the above-mentioned medicines are prepared, they are crushed through a 200-mesh sieve, and the fine powder is packed into capsules to obtain the oral capsule preparation of the present invention. Dosage: 6-10 grams per serving, 2-3 times a day.

[0068] Embodiment 3 of the external application preparation of the present invention consists of the following components in parts by weight:

[0069]

[0070] After the above-mentioned medicines are proportioned according to the dosage, they are crushed into a coarse powder, and the coarse powder is packed into a 100-gram pouch, steamed in an oven, and then applied to the abdomen externally, once every day.

[0071] Below in conjunction with some specific typical cases, the oral administration and external application preparation efficacy of the product of the present i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Chinese medicinal compound preparation for treating uterine myoma. The Chinese medicinal compound preparation consists of a preparation for oral administration and a preparation for external application, wherein the preparation for oral administration comprises the following components in part by weight: 5 to 15 parts of Chinese angelica, 5 to 15 parts of szechuan lovagerhizome, 5 to 15 parts of rehmanniae vaporata, 5 to 15 parts of white paeony root, 6 to 18 parts of salivia chinensis, 6 to 18 parts of fibrous ginseng root, 5 to 15 parts of pangolin scales (concoction), 5 to 15 parts of common burreed rhizome, 10 to 20 parts of zedoary, 25 to 35 parts of calcined oyster shell, 5 to 15 parts of scrophularia root, 6 to 18 parts of root of red-rooted salvia, 6 to 18 parts of dipsacus root, 5 to 15 parts of poria, 5 to 15 parts of panax notoginseng, 5 to 15 parts of kelp, 15 to 25 parts of european verbena, 5 to 15 parts of cowherb seed, 5 to 15 parts of Indian iphigenia bulb and 5 to 15 parts of brittle falsepimpernel herb; and the preparation for external application comprises the following components in part by weight: 4 to 16 parts of nux vomica, 5 to 15 parts of pnus massoniana leaf, 5 to 17 parts of siam psychotria leaf, 4 to 15 parts of bead tree leaf, 3 to 16 parts of whiteflower leadword root leaf, 5 to 16 parts of common jasminorange leaf and twig and 4 to 17 parts of glechoma hederacea L. The Chinese medicinal compound preparation for treating the uterine myoma has the advantages of short course of treatment, definite and obvious curative effect and no side effect by applying the pharmacology and medicinal effect of the oral administration and external application of traditional Chinese medicines.

Description

technical field [0001] The invention relates to a traditional Chinese medicine compound preparation for treating uterine fibroids. Background technique [0002] Uterine fibroids are the most common benign tumors in the female reproductive organs. It is formed by the proliferation of uterine smooth muscle cells, which contains a small amount of fibrous connective tissue, but it is not the basic component of fibroids, so its exact diagnosis should be "uterine leiomyoma", commonly known as "uterine fibroids". The clinical manifestations of uterine fibroids often vary with the location, size, growth rate, secondary degeneration, and complications of the fibroids. Clinically, many patients are asymptomatic and are only discovered occasionally during pelvic examination, about 20% -50% The common symptoms of fibroids are uterine bleeding, abdominal mass, pain, compression symptoms of adjacent organs, increased leucorrhea, infertility, secondary anemia and cardiac dysfunction. The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61K36/75A61P35/00A61P15/00A61K35/36A61K35/56A61K35/618
Inventor 王元林李汉超
Owner ZHONGSHAN HYGENE BIOPHARM